logo
logo
Sign in

Cushings Syndrome Market Global Outlook, Research, Trends And Forecast To 2025

avatar
Anjali Pawar
Cushings Syndrome Market Global Outlook, Research, Trends And Forecast To 2025

Cushing's syndrome is a rare medical condition caused by the excessive production of cortisol hormone by the adrenal gland. The disorder leads to a wide range of symptoms such as weight gain, high blood pressure, osteoporosis, muscle weakness, and depression, among others. The prevalence of the disorder is estimated to be 10 to 15 cases per million people per year, with women being affected three times more than men. The market for Cushing's syndrome treatment is expected to grow significantly in the coming years due to the increasing prevalence of the disorder and the launch of new therapies.


The global Cushings Syndrome Market was valued at $1.4 billion in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 9.2% from 2021 to 2028. The growth is attributed to the increasing prevalence of the disorder, the launch of new therapies, and the rising awareness of the condition among patients and healthcare providers. The market is expected to be driven by the United States, where a high prevalence of the disorder is observed.


The market is segmented into three categories based on the type of treatment, namely medication, surgery, and radiation therapy. The medication segment is expected to hold the largest market share due to the availability of various drugs for the treatment of Cushing's syndrome. The surgery segment is also expected to witness significant growth due to the increasing adoption of surgical procedures for the treatment of the disorder. The radiation therapy segment is expected to witness slow growth due to the low adoption rate of the therapy.


The major players in the Cushing's syndrome treatment market are Corcept Therapeutics, HRA Pharma, Novartis, and Recordati. These companies are focusing on developing new therapies for the treatment of the disorder and are investing heavily in research and development. The launch of new therapies is expected to drive the growth of the market in the coming years. The demand for Cushing's syndrome treatment is driven by the increasing prevalence of the disorder, rising awareness among patients and healthcare providers, and the availability of new therapies. The disorder is more prevalent in women than men, with a female-to-male ratio of 3:1. The disorder is also more common in people between the ages of 20 and 50.


Read more @ https://influentialblogging.blogspot.com/2023/03/increasing-cases-of-cushings-disease-to.html


collect
0
avatar
Anjali Pawar
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more